P2.11C.01 With Eyes on the Future: Prospective Evaluation of Immune-Related Adverse Events in Patients with Lung Cancer
Back to course
Pdf Summary
Asset Subtitle
Lauren Kiel
Meta Tag
Speaker Lauren Kiel
Topic Metastatic NSCLC – Immunotherapy
Keywords
immune-related adverse events
lung cancer
immunotherapy
immune checkpoint inhibitors
Pembrolizumab
Durvalumab
patient-reported symptoms
Dana-Farber Cancer Institute
Harvard Medical School
ICI tolerability
Powered By